Bulgaria's Sopharma reports 4% decrease in Q1 sales as exports fall

Bulgaria's Sopharma reports 4% decrease in Q1 sales as exports fall

Bulgarian drug maker Sopharma said on Monday that its sales revenue fell by an annual 4% in the first quarter of 2020, due to a 6% decrease in sales on foreign markets. In March alone, Sopharma's sales rose 11% due to a 21% jump in exports, the company said in a bourse filing. The company did not disclose information about the volume of its sales or amount of sales revenue. As at 12:30 CET on Monday, Sopharma shares traded at 2.42% higher at 2.96 levs ($1.63/1.51 euro) on the Bulgarian Stock Exchange.

Cookies Preferences
Choose Type of Cookies You Accept Using

These cookies are required for the website to run and cannot be switched off. Such cookie are only set in response to actions made by you such as language, currency, login session, privacy preferences. You can set your browser to block these cookies but our site may not work then.

These cookies allow us to measure visitors traffic and see traffic sources by collecting information in data sets. They also help us understand which products and actions are more popular than others.

These cookies are usually set by our marketing and advertising partners. They may be used by them to build a profile of your interest and later show you relevant ads. If you do not allow these cookies you will not experience targeted ads for your interests.